Cargando…
Prevention and management of adverse events of novel agents in multiple myeloma: a consensus of the European Myeloma Network
During the last few years, several new drugs have been introduced for treatment of patients with multiple myeloma, which have significantly improved the treatment outcome. All of these novel substances differ at least in part in their mode of action from similar drugs of the same drug class, or are...
| Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6035147/ https://www.ncbi.nlm.nih.gov/pubmed/29720735 http://dx.doi.org/10.1038/s41375-018-0040-1 |
| _version_ | 1783337992808562688 |
|---|---|
| author | Ludwig, Heinz Delforge, Michel Facon, Thierry Einsele, Hermann Gay, Francesca Moreau, Philippe Avet-Loiseau, Hervé Boccadoro, Mario Hajek, Roman Mohty, Mohamad Cavo, Michele Dimopoulos, Meletios A San-Miguel, Jesús F Terpos, Evangelos Zweegman, Sonja Garderet, Laurent Mateos, María-Victoria Cook, Gordon Leleu, Xavier Goldschmidt, Hartmut Jackson, Graham Kaiser, Martin Weisel, Katja van de Donk, Niels W. C. J. Waage, Anders Beksac, Meral Mellqvist, Ulf H. Engelhardt, Monika Caers, Jo Driessen, Christoph Bladé, Joan Sonneveld, Pieter |
| author_facet | Ludwig, Heinz Delforge, Michel Facon, Thierry Einsele, Hermann Gay, Francesca Moreau, Philippe Avet-Loiseau, Hervé Boccadoro, Mario Hajek, Roman Mohty, Mohamad Cavo, Michele Dimopoulos, Meletios A San-Miguel, Jesús F Terpos, Evangelos Zweegman, Sonja Garderet, Laurent Mateos, María-Victoria Cook, Gordon Leleu, Xavier Goldschmidt, Hartmut Jackson, Graham Kaiser, Martin Weisel, Katja van de Donk, Niels W. C. J. Waage, Anders Beksac, Meral Mellqvist, Ulf H. Engelhardt, Monika Caers, Jo Driessen, Christoph Bladé, Joan Sonneveld, Pieter |
| author_sort | Ludwig, Heinz |
| collection | PubMed |
| description | During the last few years, several new drugs have been introduced for treatment of patients with multiple myeloma, which have significantly improved the treatment outcome. All of these novel substances differ at least in part in their mode of action from similar drugs of the same drug class, or are representatives of new drug classes, and as such present with very specific side effect profiles. In this review, we summarize these adverse events, provide information on their prevention, and give practical guidance for monitoring of patients and for management of adverse events. |
| format | Online Article Text |
| id | pubmed-6035147 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2018 |
| publisher | Nature Publishing Group UK |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-60351472018-07-09 Prevention and management of adverse events of novel agents in multiple myeloma: a consensus of the European Myeloma Network Ludwig, Heinz Delforge, Michel Facon, Thierry Einsele, Hermann Gay, Francesca Moreau, Philippe Avet-Loiseau, Hervé Boccadoro, Mario Hajek, Roman Mohty, Mohamad Cavo, Michele Dimopoulos, Meletios A San-Miguel, Jesús F Terpos, Evangelos Zweegman, Sonja Garderet, Laurent Mateos, María-Victoria Cook, Gordon Leleu, Xavier Goldschmidt, Hartmut Jackson, Graham Kaiser, Martin Weisel, Katja van de Donk, Niels W. C. J. Waage, Anders Beksac, Meral Mellqvist, Ulf H. Engelhardt, Monika Caers, Jo Driessen, Christoph Bladé, Joan Sonneveld, Pieter Leukemia Review Article During the last few years, several new drugs have been introduced for treatment of patients with multiple myeloma, which have significantly improved the treatment outcome. All of these novel substances differ at least in part in their mode of action from similar drugs of the same drug class, or are representatives of new drug classes, and as such present with very specific side effect profiles. In this review, we summarize these adverse events, provide information on their prevention, and give practical guidance for monitoring of patients and for management of adverse events. Nature Publishing Group UK 2018-05-02 2018 /pmc/articles/PMC6035147/ /pubmed/29720735 http://dx.doi.org/10.1038/s41375-018-0040-1 Text en © The Author(s) 2018 Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. If you remix, transform, or build upon this article or a part thereof, you must distribute your contributions under the same license as the original. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/. |
| spellingShingle | Review Article Ludwig, Heinz Delforge, Michel Facon, Thierry Einsele, Hermann Gay, Francesca Moreau, Philippe Avet-Loiseau, Hervé Boccadoro, Mario Hajek, Roman Mohty, Mohamad Cavo, Michele Dimopoulos, Meletios A San-Miguel, Jesús F Terpos, Evangelos Zweegman, Sonja Garderet, Laurent Mateos, María-Victoria Cook, Gordon Leleu, Xavier Goldschmidt, Hartmut Jackson, Graham Kaiser, Martin Weisel, Katja van de Donk, Niels W. C. J. Waage, Anders Beksac, Meral Mellqvist, Ulf H. Engelhardt, Monika Caers, Jo Driessen, Christoph Bladé, Joan Sonneveld, Pieter Prevention and management of adverse events of novel agents in multiple myeloma: a consensus of the European Myeloma Network |
| title | Prevention and management of adverse events of novel agents in multiple myeloma: a consensus of the European Myeloma Network |
| title_full | Prevention and management of adverse events of novel agents in multiple myeloma: a consensus of the European Myeloma Network |
| title_fullStr | Prevention and management of adverse events of novel agents in multiple myeloma: a consensus of the European Myeloma Network |
| title_full_unstemmed | Prevention and management of adverse events of novel agents in multiple myeloma: a consensus of the European Myeloma Network |
| title_short | Prevention and management of adverse events of novel agents in multiple myeloma: a consensus of the European Myeloma Network |
| title_sort | prevention and management of adverse events of novel agents in multiple myeloma: a consensus of the european myeloma network |
| topic | Review Article |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6035147/ https://www.ncbi.nlm.nih.gov/pubmed/29720735 http://dx.doi.org/10.1038/s41375-018-0040-1 |
| work_keys_str_mv | AT ludwigheinz preventionandmanagementofadverseeventsofnovelagentsinmultiplemyelomaaconsensusoftheeuropeanmyelomanetwork AT delforgemichel preventionandmanagementofadverseeventsofnovelagentsinmultiplemyelomaaconsensusoftheeuropeanmyelomanetwork AT faconthierry preventionandmanagementofadverseeventsofnovelagentsinmultiplemyelomaaconsensusoftheeuropeanmyelomanetwork AT einselehermann preventionandmanagementofadverseeventsofnovelagentsinmultiplemyelomaaconsensusoftheeuropeanmyelomanetwork AT gayfrancesca preventionandmanagementofadverseeventsofnovelagentsinmultiplemyelomaaconsensusoftheeuropeanmyelomanetwork AT moreauphilippe preventionandmanagementofadverseeventsofnovelagentsinmultiplemyelomaaconsensusoftheeuropeanmyelomanetwork AT avetloiseauherve preventionandmanagementofadverseeventsofnovelagentsinmultiplemyelomaaconsensusoftheeuropeanmyelomanetwork AT boccadoromario preventionandmanagementofadverseeventsofnovelagentsinmultiplemyelomaaconsensusoftheeuropeanmyelomanetwork AT hajekroman preventionandmanagementofadverseeventsofnovelagentsinmultiplemyelomaaconsensusoftheeuropeanmyelomanetwork AT mohtymohamad preventionandmanagementofadverseeventsofnovelagentsinmultiplemyelomaaconsensusoftheeuropeanmyelomanetwork AT cavomichele preventionandmanagementofadverseeventsofnovelagentsinmultiplemyelomaaconsensusoftheeuropeanmyelomanetwork AT dimopoulosmeletiosa preventionandmanagementofadverseeventsofnovelagentsinmultiplemyelomaaconsensusoftheeuropeanmyelomanetwork AT sanmigueljesusf preventionandmanagementofadverseeventsofnovelagentsinmultiplemyelomaaconsensusoftheeuropeanmyelomanetwork AT terposevangelos preventionandmanagementofadverseeventsofnovelagentsinmultiplemyelomaaconsensusoftheeuropeanmyelomanetwork AT zweegmansonja preventionandmanagementofadverseeventsofnovelagentsinmultiplemyelomaaconsensusoftheeuropeanmyelomanetwork AT garderetlaurent preventionandmanagementofadverseeventsofnovelagentsinmultiplemyelomaaconsensusoftheeuropeanmyelomanetwork AT mateosmariavictoria preventionandmanagementofadverseeventsofnovelagentsinmultiplemyelomaaconsensusoftheeuropeanmyelomanetwork AT cookgordon preventionandmanagementofadverseeventsofnovelagentsinmultiplemyelomaaconsensusoftheeuropeanmyelomanetwork AT leleuxavier preventionandmanagementofadverseeventsofnovelagentsinmultiplemyelomaaconsensusoftheeuropeanmyelomanetwork AT goldschmidthartmut preventionandmanagementofadverseeventsofnovelagentsinmultiplemyelomaaconsensusoftheeuropeanmyelomanetwork AT jacksongraham preventionandmanagementofadverseeventsofnovelagentsinmultiplemyelomaaconsensusoftheeuropeanmyelomanetwork AT kaisermartin preventionandmanagementofadverseeventsofnovelagentsinmultiplemyelomaaconsensusoftheeuropeanmyelomanetwork AT weiselkatja preventionandmanagementofadverseeventsofnovelagentsinmultiplemyelomaaconsensusoftheeuropeanmyelomanetwork AT vandedonknielswcj preventionandmanagementofadverseeventsofnovelagentsinmultiplemyelomaaconsensusoftheeuropeanmyelomanetwork AT waageanders preventionandmanagementofadverseeventsofnovelagentsinmultiplemyelomaaconsensusoftheeuropeanmyelomanetwork AT beksacmeral preventionandmanagementofadverseeventsofnovelagentsinmultiplemyelomaaconsensusoftheeuropeanmyelomanetwork AT mellqvistulfh preventionandmanagementofadverseeventsofnovelagentsinmultiplemyelomaaconsensusoftheeuropeanmyelomanetwork AT engelhardtmonika preventionandmanagementofadverseeventsofnovelagentsinmultiplemyelomaaconsensusoftheeuropeanmyelomanetwork AT caersjo preventionandmanagementofadverseeventsofnovelagentsinmultiplemyelomaaconsensusoftheeuropeanmyelomanetwork AT driessenchristoph preventionandmanagementofadverseeventsofnovelagentsinmultiplemyelomaaconsensusoftheeuropeanmyelomanetwork AT bladejoan preventionandmanagementofadverseeventsofnovelagentsinmultiplemyelomaaconsensusoftheeuropeanmyelomanetwork AT sonneveldpieter preventionandmanagementofadverseeventsofnovelagentsinmultiplemyelomaaconsensusoftheeuropeanmyelomanetwork |